Skip links
Companies
› United States › INSIGHT MOLECULAR DIAGNOSTICS INC.
Company registry profile
INSIGHT MOLECULAR DIAGNOSTICS INC. logo

INSIGHT MOLECULAR DIAGNOSTICS INC.

Public Limited Company Active

in

From the registry

Registration details

Registration No.
3231738
Incorporation Date
2009-09-30
Company Type
Public Limited Company
Address
NASHVILLE, United States
Website
www.oncocyte.com/
Status
Active
Country
United States
Source: California Secretary of State — bizfile OnlineRegistry coverage
Registry summary

Company overview

INSIGHT MOLECULAR DIAGNOSTICS INC. is a Public Limited Company registered in United States under 3231738, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 30 September 2009 and lists its registered address as NASHVILLE, United States. 4 shareholders are on record for INSIGHT MOLECULAR DIAGNOSTICS INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.

Data Provenance
This record is sourced directly from official government registries, including California Secretary of State — bizfile Online.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

4

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Vanguard Group Inc 3.1% California Secretary of State — bizfile Online
Wealthedge Investment Advisors, LLC 0.4% California Secretary of State — bizfile Online

Registry notes and limitations

Four shareholders are currently on record for INSIGHT MOLECULAR DIAGNOSTICS INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 3.1% — the largest recorded stake — followed by Wealthedge Investment Advisors, LLC at 0.4%; the remaining 2 shareholders shown hold smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

5

WA
WILLAIM ANNETT ACTIVE

Residence
🇺🇸 United States
Occupation
Ceo

BC
BRIAN CULLEY ACTIVE

Residence
🇺🇸 United States
Occupation
President

WA
WILLIAM ANNETT ACTIVE

Residence
🇺🇸 United States
Occupation
President

RS
RUSSELL SKIBSTED ACTIVE

Residence
🇺🇸 United States
Occupation
Cfo

MW
MICHAEL WEST ACTIVE

Residence
🇺🇸 United States
Occupation
President

Registry notes and limitations

The Ceo of INSIGHT MOLECULAR DIAGNOSTICS INC. currently on record is WILLAIM ANNETT; five officers are currently on record for INSIGHT MOLECULAR DIAGNOSTICS INC., filed with California Secretary of State — bizfile Online.

The register reports 26 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at INSIGHT MOLECULAR DIAGNOSTICS INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Group Structure

Top of recorded group
INSIGHT MOLECULAR DIAGNOSTICS INC.
United States
Chronix Biomedical, Inc.+ subsidiaries
United StatesUS CA 3223451

Insight Genetics, Inc.
United StatesUS TN 000484334

Razor Genomics, Inc.
United States#0228788627

How these relationships were recorded

INSIGHT MOLECULAR DIAGNOSTICS INC. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 3 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 3 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Registry questions

Frequently asked questions

Who owns INSIGHT MOLECULAR DIAGNOSTICS INC.?

Four shareholders are currently on record for INSIGHT MOLECULAR DIAGNOSTICS INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 3.1% — the largest recorded stake — followed by Wealthedge Investment Advisors, LLC at 0.4%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is INSIGHT MOLECULAR DIAGNOSTICS INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for INSIGHT MOLECULAR DIAGNOSTICS INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does INSIGHT MOLECULAR DIAGNOSTICS INC. have on record?

4 shareholders are shown on record for INSIGHT MOLECULAR DIAGNOSTICS INC..

What is INSIGHT MOLECULAR DIAGNOSTICS INC.'s company registration number?

INSIGHT MOLECULAR DIAGNOSTICS INC.'s registration number is 3231738, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.

Is INSIGHT MOLECULAR DIAGNOSTICS INC. still an active company?

INSIGHT MOLECULAR DIAGNOSTICS INC.'s status on California Secretary of State — bizfile Online is listed as active.

When was INSIGHT MOLECULAR DIAGNOSTICS INC. incorporated?

INSIGHT MOLECULAR DIAGNOSTICS INC. was incorporated on 30 September 2009, according to California Secretary of State — bizfile Online.

What is INSIGHT MOLECULAR DIAGNOSTICS INC.'s registered address?

The registered address on file for INSIGHT MOLECULAR DIAGNOSTICS INC. is NASHVILLE, United States.

What legal structure is INSIGHT MOLECULAR DIAGNOSTICS INC. registered as?

INSIGHT MOLECULAR DIAGNOSTICS INC. is registered as a Public Limited Company in United States.

Who are the officers/directors of INSIGHT MOLECULAR DIAGNOSTICS INC.?

The Ceo of INSIGHT MOLECULAR DIAGNOSTICS INC. currently on record is WILLAIM ANNETT; five officers are currently on record for INSIGHT MOLECULAR DIAGNOSTICS INC., filed with California Secretary of State — bizfile Online. Management authority at INSIGHT MOLECULAR DIAGNOSTICS INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does INSIGHT MOLECULAR DIAGNOSTICS INC. have a parent company or subsidiaries?

INSIGHT MOLECULAR DIAGNOSTICS INC. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Those 3 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 3 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Other companies in United States

All companies in United States

This website uses cookies to improve your web experience.